Admittedly, INFI stock is extremely speculative. Nevertheless, a little bit of positive news could go a long way for …
Keep in mind that its stock has now doubled from its post-IPO low. GoPro shares were down by 5% at $56.86 in early …
A year ago, they were trading at $3.10. This story was generated by Automated Insights (http://automatedinsights.com/ap) using data from Zacks Investment Research. Access a Zacks stock report on INFI at https://www.zacks.com/ap/INFI
2. Tandem Diabetes Care Inc. (TNDM) Lost 17.89% to close Thursday's trading at $4.68. News: The Company is proposing to offer and sell shares of its common stock, Series A warrants and Series B warrants to purchase shares of its …
Feb. 10, 2010 (GLOBE NEWSWIRE) -- Infinity Pharmaceuticals, Inc. (Nasdaq:INFI), an innovative drug discovery and …
Infinity Pharmaceuticals Inc. (NASDAQ: INFI) saw its shares almost double early on Thursday ... Excluding Thursday’s move, Infinity Pharma has outperformed the U.S. broad markets, with the stock up about 24% year to date. Over the …
Infinity Pharmaceuticals, Inc. (NASDAQ: INFI) today announced the closing of an underwritten public offering of its …
If you are still interested in the Medical - Drugs industry, you may instead consider a better-ranked stock - Infinity Pharmaceuticals, Inc. INFI. The stock currently holds a Zacks Rank #1 (Strong Buy) and may be a better selection at …
Infinity Pharmaceuticals Inc. (INFI) announced Tuesday morning that its Phase 2 study ... Shares finished down by 3.05 at $1.36 on the highest volume of the year. The stock plunged to a new low for the year.